These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9226292)

  • 1. Restenosis or rapid progression in non-dilated sites are not predictors of late spontaneous coronary events.
    Benchimol D; Dubroca B; Dufourq P; Benchimol H; Couffinhal T; Dartigues JF; Bonnet J
    Int J Cardiol; 1997 Jul; 60(2):201-11. PubMed ID: 9226292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty.
    Weintraub WS; Ghazzal ZM; Douglas JS; Liberman HA; Morris DC; Cohen CL; King SB
    Circulation; 1993 Mar; 87(3):831-40. PubMed ID: 8443903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of coronary artery disease in non-dilated sites in the months following balloon angioplasty: time-dependent relation with restenosis.
    Benchimol D; Dartigues JF; Benchimol H; Bordier P; Duplàa C; Couffinhal T; Bonnet J
    Eur J Clin Invest; 1995 Dec; 25(12):935-41. PubMed ID: 8719934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty.
    Benchimol D; Bonnet J; Benchimol H; Drouillet F; Duplaa C; Couffinhal T; Desgranges C; Bricaud H
    Int J Cardiol; 1993 Jan; 38(1):7-18. PubMed ID: 8444504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local lesion-related factors and restenosis after coronary angioplasty. Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty.
    de Groote P; Bauters C; McFadden EP; Lablanche JM; Leroy F; Bertrand ME
    Circulation; 1995 Feb; 91(4):968-72. PubMed ID: 7850983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive pattern of angina after successful coronary angioplasty: the role of clinical and angiographic factors.
    Chen L; Leatham E; Chester M; Huang J; Kaski JC
    Eur Heart J; 1995 Aug; 16(8):1085-91. PubMed ID: 8665970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angioscopic predictors of restenosis following coronary angioplasty--the impact of yellow smooth plaques.
    Höher M; Hombach V; Wöhrle J
    Z Kardiol; 2001 Feb; 90(2):111-9. PubMed ID: 11263000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of coronary events after successful coronary angioplasty.
    Ishiwata S; Nakanishi S; Nishiyama S; Seki A
    Coron Artery Dis; 1996 Aug; 7(8):573-7. PubMed ID: 8922884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
    Bauters C; Khanoyan P; McFadden EP; Quandalle P; Lablanche JM; Bertrand ME
    Circulation; 1995 Mar; 91(5):1410-8. PubMed ID: 7867181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a third coronary angioplasty for a second restenosis: short-term results, long-term follow up, and correlates of a third restenosis.
    Tan KH; Sulke N; Taub N; Karani S; Sowton E
    Br Heart J; 1995 Apr; 73(4):327-33. PubMed ID: 7756065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five years of angiographic and clinical follow-up after successful percutaneous transluminal coronary angioplasty.
    Guiteras P; Tomas L; Varas C; Augé JM; Masotti M; Crexells C; Oriol A
    Eur Heart J; 1989 Dec; 10 Suppl G():42-8. PubMed ID: 2627948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and sequential angiographic follow-up six months and 10 years after successful percutaneous transluminal coronary angioplasty.
    Guiteras-Val P; Varas-Lorenzo C; Garcia-Picart J; Martí-Claramunt V; Augé-Sanpera JM
    Am J Cardiol; 1999 Mar; 83(6):868-74. PubMed ID: 10190401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
    Bertrand ME; McFadden EP; Fruchart JC; Van Belle E; Commeau P; Grollier G; Bassand JP; Machecourt J; Cassagnes J; Mossard JM; Vacheron A; Castaigne A; Danchin N; Lablanche JM
    J Am Coll Cardiol; 1997 Oct; 30(4):863-9. PubMed ID: 9316510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Rensing BJ; Foley DP; Deckers JW; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Am Coll Cardiol; 1992 Oct; 20(4):767-80. PubMed ID: 1388181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
    Kotamäki M; Laustiola K; Syvänne M; Heikkilä J
    J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat percutaneous coronary angioplasty; clinical and angiographic follow-up in patients with stable or unstable angina pectoris.
    Bauters C; Lablanche JM; McFadden EP; Leroy F; Bertrand ME
    Eur Heart J; 1993 Feb; 14(2):235-9. PubMed ID: 8449200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Foley DP; Rensing BJ; Serruys PW
    Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.
    Faxon DP
    J Am Coll Cardiol; 1995 Feb; 25(2):362-9. PubMed ID: 7829789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the substitution of nonangiographic end points (death, acute myocardial infarction, coronary bypass and/or repeat angioplasty) for follow-up coronary angiography in evaluating the success of coronary angioplasty in patients with angina pectoris.
    Weintraub WS; Ghazzal ZM; Douglas JS; Morris DC; King SB
    Am J Cardiol; 1998 Feb; 81(4):382-6. PubMed ID: 9485123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.